Login to Your Account



31st Annual J.P. Morgan Healthcare Conference

Keryx: Zerenex Data Held Hostage by Hurricane Sandy

By Marie Powers
Staff Writer

Friday, January 11, 2013
Ron Bentsur, CEO of Keryx Biopharmaceuticals Inc., disappointed some attendees on the final morning of the J.P. Morgan Healthcare Conference when he acknowledged the company is still waiting for Phase III data on Zerenex (ferric citrate) in end-stage renal disease (ESRD) patients with hyperphosphatemia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription